Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review

Liuyan Xu; Xiaohua Pei; Xuan Wang; Baoyong Lai; Xinyan Jin; Yingyi Fan

doi:10.1016/j.jtcms.2023.03.006

您当前的位置：

首页 >

文章列表页 >

Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review

Full-length article | 更新时间：2023-05-16

- Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review
- Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review
- Genes & Diseases 2023年10卷第2期
- 作者机构：
  
  1. Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine,Beijing,China,102488
  2. Xiamen Hospital of Traditional Chinese Medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine,Xiamen,China,361001
  3. Third Affiliated Hospital of Beijing University of Chinese Medicine,Beijing,China,100029
- 作者简介：
- 基金信息：
- DOI：10.1016/j.jtcms.2023.03.006
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-4-1，
扫描看全文
Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review[J]. Genes & Diseases, 2023,10(2).

Liuyan Xu, Xiaohua Pei, Xuan Wang, et al. Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review[J]. Genes & Diseases, 2023,10(2).
Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.jtcms.2023.03.006.

Liuyan Xu, Xiaohua Pei, Xuan Wang, et al. Current status of outcome reporting in randomized controlled trials of traditional Chinese medicine for mammary gland hyperplasia: A systematic review[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.jtcms.2023.03.006.

摘要

Abstract

ObjectiveTo assess outcome indicators in clinical trials and provide a reference for establishing a core outcome set to treat hyperplasia of mammary gland (HMG) with traditional Chinese medicine (TCM).

关键词

Keywords

Traditional Chinese medicineHyperplasia of mammary glandsRandomized controlled trialsOutcome indicatorCore outcome set

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Application of evidence-based medicine methods in integrative oncology research

Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future